Billionaire Jeff Ubben’s Top Five Long-Term Picks

#1 Valeant Pharmaceuticals Intl Inc (NYSE:VRX)

Shares held (as of September 30): 14.99 million
Total Value (as of September 30): $2.67 billion
Percent of Portfolio (as of September 30): 15.55%

It seems Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is successfully recovering from its ugly sell-off. Shares of the embattled drug maker have broken above the $100 per share level on several bits of positive news, including a new distribution deal with Walgreens Boots Alliance Inc (NASDAQ:WBA) and optimistic 2016 guidance, with management expecting revenue between $12.5 billion and $12.7 billion and Non-GAAP EPS of $13.25 to $13.75 for next year. Perhaps more importantly,Valeant still counts many top investors among its shareholders, including Bill Ackman’s Pershing Square, which owns 9.9% of the company. As long as Ackman holds shares, many investors will remain confident in the stock.

Disclosure: none